{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:56:59Z","timestamp":1783699019776,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ad.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:04:50Z","timestamp":1559034290000},"page":"642-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Osteoporosis y psoriasis"],"prefix":"10.1016","volume":"110","author":[{"given":"M.","family":"Mu\u00f1oz-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Daud\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2019.02.005_bib0285","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: A systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0290","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet."},{"key":"10.1016\/j.ad.2019.02.005_bib0295","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ad.2013.12.008","article-title":"Prevalencia de la psoriasis en Espa\u00f1a en la era de los agentes biol\u00f3gicos","volume":"105","author":"Ferr\u00e1ndiz","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.02.005_bib0300","first-page":"1354","article-title":"Incidence and prevalence of psoriatic arthritis: A systematic review","volume":"35","author":"Alamanos","year":"2008","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0305","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis co-morbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0310","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ad.2016.05.009","article-title":"Enfermedad renal y psoriasis. \u00bfUna nueva comorbilidad?","volume":"107","author":"Gonz\u00e1lez-Parra","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.02.005_bib0315","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ad.2016.12.023","article-title":"Implicaciones cl\u00ednicas, diagn\u00f3sticas y terap\u00e9uticas de la psoriasis y enfermedad cardiovascular","volume":"108","author":"Bonanad","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.02.005_bib0320","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ad.2016.12.017","article-title":"Psoriasis and nonalcoholic fatty liver disease","volume":"108","author":"Carrascosa","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2019.02.005_bib0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","article-title":"Comorbidities in psoriatic arthritis","volume":"41","author":"Husni","year":"2015","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.ad.2019.02.005_bib0330","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/annrheumdis-2016-210441","article-title":"The risk of fracture among patients with psoriatic arthritis and psoriasis: A population-based study","volume":"76","author":"Ogdie","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ad.2019.02.005_bib0335","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-018-4491-z","article-title":"Risk of fragility fracture among patients with late-onset psoriasis: A UK population-based study","volume":"29","author":"Paskins","year":"2018","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.ad.2019.02.005_bib0340","doi-asserted-by":"crossref","first-page":"e0171667","DOI":"10.1371\/journal.pone.0171667","article-title":"Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS ONE."},{"key":"10.1016\/j.ad.2019.02.005_bib0345","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1301\/nr.2007.dec.S147-S151","article-title":"Osteoporosis and inflammation","volume":"65","author":"Mundy","year":"2007","journal-title":"Nutr Rev."},{"key":"10.1016\/j.ad.2019.02.005_bib0350","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2019.02.005_bib0355","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/jdv.15177","article-title":"Position statement for the management of comorbidities in psoriasis","volume":"32","author":"Dauden","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2019.02.005_bib0360","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rce.2015.08.003","article-title":"Clinical practice guidelines for posmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014) \u2212","volume":"215","author":"Gonz\u00e1lez-Mac\u00edas","year":"2015","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.ad.2019.02.005_bib0365","series-title":"Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis","year":"1994"},{"key":"10.1016\/j.ad.2019.02.005_bib0370","unstructured":"The Internationals Society for Clinical Densitometry Official Positions. Disponible en: www.iscd.org\/Visitors\/positions\/OfficialPositionsText.cfm"},{"key":"10.1016\/j.ad.2019.02.005_bib0375","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.berh.2005.06.001","article-title":"Assessment of fracture risk: Who should be treated for osteoporosis?","volume":"19","author":"Van der Klift","year":"2005","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"Supl 1","key":"10.1016\/j.ad.2019.02.005_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2565(08)71780-6","article-title":"Gu\u00edas de pr\u00e1ctica cl\u00ednica en la osteoporosis posmenop\u00e1usica, glucocorticoidea y del var\u00f3n. Sociedad Espa\u00f1ola de Investigaci\u00f3n \u00d3sea y del Metabolismo Mineral","volume":"208","author":"Gonz\u00e1lez Mac\u00edas","year":"2008","journal-title":"Rev Clin Esp."},{"key":"10.1016\/j.ad.2019.02.005_bib0385","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAXR and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.ad.2019.02.005_bib0390","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bone.2011.11.006","article-title":"Probability of fractures predicted by FRAX\u00ae and observed incidence in the Spanish ECOSAP Study cohort","volume":"50","author":"Gonz\u00e1lez-Mac\u00edas","year":"2012","journal-title":"Bone."},{"key":"10.1016\/j.ad.2019.02.005_bib0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medcli.2013.11.014","article-title":"FRAX\u00ae thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population","volume":"144","author":"Azagra","year":"2015","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.ad.2019.02.005_bib0400","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3892\/ijmm.2013.1269","article-title":"Temporal differential effects of proinflammatory cytokines on osteoclastogenesis","volume":"31","author":"Moon","year":"2013","journal-title":"Int J Mol Med."},{"issue":"Suppl 2","key":"10.1016\/j.ad.2019.02.005_bib0405","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.reuma.2011.03.003","article-title":"Osteoblast-osteoclast interaction mechanisms","volume":"7","author":"Riancho","year":"2011","journal-title":"Reumatol Clin."},{"key":"10.1016\/j.ad.2019.02.005_bib0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front Immunol."},{"key":"10.1016\/j.ad.2019.02.005_bib0415","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar2219","article-title":"A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and non responders to infliximab","volume":"9","author":"Marotte","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ad.2019.02.005_bib0420","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/rheumatology\/kei082","article-title":"Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-\u03b1 antibody: A prospective open-label pilot study","volume":"44","author":"Lange","year":"2005","journal-title":"Rheumatology."},{"key":"10.1016\/j.ad.2019.02.005_bib0425","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1346-8138.12546","article-title":"Psoriasis and bone mineral density: Implications for long-term patients","volume":"41","author":"D\u2019Epiro","year":"2014","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0430","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s00198-012-2185-5","article-title":"Association between osteoporosis and psoriasis: Results from the Longitudinal Health Insurance Database in Taiwan","volume":"24","author":"Keller","year":"2013","journal-title":"Osteoporos Int."},{"key":"10.1016\/j.ad.2019.02.005_bib0435","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-007-0725-8","article-title":"Bone mineral density and bone turnover in patients with psoriatic arthritis","volume":"27","author":"Borman","year":"2008","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0440","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-4632.2010.04600.x","article-title":"Assessment of osteoporosis in psoriasis with and without arthritis: Correlation with disease severity","volume":"50","author":"Attia","year":"2011","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0445","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2016.05.005","article-title":"Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review","volume":"46","author":"Chandran","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ad.2019.02.005_bib0450","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11657-012-0112-1","article-title":"Psoriasis and osteoporosis: Data from a Southern Italian population","volume":"7","author":"Balato","year":"2012","journal-title":"Arch Osteoporos."},{"key":"10.1016\/j.ad.2019.02.005_bib0455","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar3240","article-title":"Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis","volume":"13","author":"Pedreira","year":"2011","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.ad.2019.02.005_bib0460","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2016.11.046","article-title":"Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures","volume":"76","author":"Kathuria","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0465","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.bor.0000127824.42507.68","article-title":"Bone loss in inflammatory arthritis: Mechanisms and treatment strategies","volume":"16","author":"Walsh","year":"2004","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0470","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G","article-title":"Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup study","volume":"42","author":"Gratacos","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2019.02.005_bib0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4321\/S1889-836X2017000100007","article-title":"Osteoporosis en enfermedades reum\u00e1ticas e inducida por glucocorticoides","volume":"9","author":"Maldonado","year":"2017","journal-title":"Rev Osteoporos Metab Miner."},{"key":"10.1016\/j.ad.2019.02.005_bib0480","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/jid.2008.432","article-title":"Psoriasis and osteoporosis: A sex-specific association?","volume":"129","author":"Dreiher","year":"2009","journal-title":"J Invest Dermatol."},{"issue":"Suppl 1","key":"10.1016\/j.ad.2019.02.005_bib0485","first-page":"AB51","article-title":"Association of moderate to severe psoriasis with osteopenia: A cross-sectional study with control group","volume":"76","author":"Martinez-Lopez","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0490","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/jbmr.2521","article-title":"Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients","volume":"30","author":"Kocijan","year":"2015","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.ad.2019.02.005_bib0495","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/phpp.12239","article-title":"Bone mineral density, 25-OH vitamin D and inflammation in patients with psoriasis","volume":"32","author":"Solak","year":"2016","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"10.1016\/j.ad.2019.02.005_bib0500","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/bjd.15123","article-title":"Psoriasis, fracture risk and bone mineral density: The HUNT Study, Norway","volume":"176","author":"Modalsli","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0505","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/09546634.2014.933164","article-title":"A case of multiple bone fractures due to the use of topical corticosteroid therapy for psoriasis","volume":"26","author":"G\u00f6n\u00fcl","year":"2015","journal-title":"J Dermatol Treat."},{"key":"10.1016\/j.ad.2019.02.005_bib0510","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1365-2133.2009.09327.x","article-title":"Low bone mineral density in adult patients with moderate to severe atopic dermatitis","volume":"161","author":"Haeck","year":"2009","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0515","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2310\/7750.2006.00065","article-title":"Lack of significant skeletal changes after long-term low-dose retinoid therapy: Case report and review of the literature","volume":"10","author":"Halverstam","year":"2006","journal-title":"J Cutaneous Med Sur."},{"key":"10.1016\/j.ad.2019.02.005_bib0520","first-page":"1489","article-title":"Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis","volume":"24","author":"Buckley","year":"1997","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0525","first-page":"251","article-title":"Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: Possible mechanism of MTX osteopathy","volume":"28","author":"Uehara","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0530","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/jbmr.2214","article-title":"Longitudinal changes in BMD and fracture risk in orthotopic liver transplant recipients not using bone-modifying treatment","volume":"29","author":"Krol","year":"2014","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.ad.2019.02.005_bib0535","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ad.2019.02.005_bib0540","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/ced.13381","article-title":"Association between circulating 25-hydroxyvitaminD levels and psoriasis, and correlation with disease severity: A meta-analysis","volume":"43","author":"Lee","year":"2018","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2019.02.005_bib0545","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ckj\/sfv114","article-title":"Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: A case series","volume":"9","author":"Balak","year":"2016","journal-title":"Clinical Kidney J"},{"key":"10.1016\/j.ad.2019.02.005_bib0550","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI29449","article-title":"Resurrection of vitamin D deficiency and rickets","volume":"116","author":"Holick","year":"2006","journal-title":"J Clin Invest."},{"key":"10.1016\/j.ad.2019.02.005_bib0555","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ecl.2010.02.010","article-title":"Vitamin D and the immune system: New perspectives on an old theme","volume":"39","author":"Hewison","year":"2010","journal-title":"Endocrinol Metab Clin North Am."},{"key":"10.1016\/j.ad.2019.02.005_bib0560","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000485132","article-title":"Vitamin D and the pathophysiology of inflammatory skin diseases","volume":"31","author":"Umar","year":"2018","journal-title":"Skin Pharmacol Physiol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:08:51Z","timestamp":1757552931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731019301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0001731019301024"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2019.02.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis y psoriasis","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}